Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compliance in the real world.

S Andrade1

  • 1Department of Applied Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoupling of biotic and abiotic patterns in a coastal area affected by chronic metal micronutrients disturbances.

Marine pollution bulletin·2021
Same author

Angiogenesis and inflammation at the crossroads between diabetes and cancer: <b>PS226</b>.

Porto biomedical journal·2020
Same author

Detection of sentinel bacteria in mangrove sediments contaminated with heavy metals.

Marine pollution bulletin·2019
Same author

Safety of metamizole: a systematic review of the literature.

Journal of clinical pharmacy and therapeutics·2016
Same author

Projecting Health Gains: The Population Impact of New Treatments to Metastatic Breast Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer - A Systematic Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same journal

Are preference-weighted cancer-specific measures more sensitive than generic measures? A comparison of EQ-5D-5L, SF-6Dv2, FACT-8D and QLU-C10D in gastrointestinal cancers.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Development and Validation of a Brief Healthcare Insecurity Scale in a Sample of U.S. Adults Living with and without HIV.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Physician-led Switching from Reference Biologics to Biosimilars: What is the Effect on selected Health-Related Outcomes and Costs for IBD Patients in Germany?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020-2023).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles

Adherence to lipid-lowering drugs is significantly poorer in primary care settings compared to clinical trials. These findings highlight challenges in maintaining patient compliance with antihyperlipidemic medications.

Area of Science:

  • Pharmacology and Therapeutics
  • Public Health and Epidemiology

Background:

  • Historically, clinical trials reported favorable discontinuation rates for lipid-lowering therapies (4-15% at 1 year, 11-30% at 5 years).
  • Cross-study comparisons are challenging due to variations in research design and data collection methods.

Purpose of the Study:

  • To evaluate patient compliance and adherence rates for antihyperlipidemic drugs in real-world primary care settings.
  • To compare adherence data from primary care with previously reported clinical trial findings.

Main Methods:

  • Review of recent studies assessing adherence to lipid-lowering medications.
  • Analysis of discontinuation rates in primary care populations across the United States, Australia, and Canada.

Main Results:

Related Experiment Videos

  • Primary care settings demonstrate substantially higher rates of drug discontinuation for lipid-lowering therapies than observed in randomized clinical trials.
  • Recent international studies consistently indicate very poor adherence to these medications in routine clinical practice.

Conclusions:

  • Patient adherence to lipid-lowering drugs is a significant issue in primary care.
  • Current evidence suggests a critical gap between clinical trial outcomes and real-world effectiveness for antihyperlipidemic treatments.